Helena Taflin

Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France.

Biolin Scientific AB develops, manufactures, markets, and sells analytical instruments and related products. Its parent company involves in the discovery of drugs, develops solutions for energy and materials, and performs research at the frontiers of science and technology. The firm's customers include companies working with pharmaceuticals, energy, chemicals, and advanced materials, as well as academic and governmental research institutes. The company was founded on September 19, 1984 and is headquartered in Vastra Frolunda, Sweden.

AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.

Part of International Business Machines Corp., IBM Svenska AB is a Swedish company that develops various computer products through the use of advanced information technology. The company is based in Stockholm, Sweden. Vahid Zohali has been the CEO of the company since 2020.

Yield Life Science AB engages in the investment and development of companies within the pharmaceutical and medical industries. Its portfolio company, Isofol Medical AB, focuses on the development of Modufolin, a rescue therapy for cancer patients. The company was founded by Anders Runo Hilmersson in 1992 and is headquartered in Gothenburg, Sweden.

Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden.

Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden.

Zetup AB provides information technology services. It offers improvement plans, product and process solutions, operations and specialist expertise. The company was founded in 2007 and is headquartered in Gothenburg, Sweden.

International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium.

Wood & Hill Investment AB acquires or invests in small and medium-sized companies. It finances real estate projects, commercial properties, and condominiums. The firm provides capital through business loans, where it creates solutions tailored to the strengths and opportunities that exist in the company and the business. It conducts business, provides consulting services in business development and management, deals with securities, stocks, mortgages, profit, or exit fee. The company was founded by Lars Martin Skoglund on September 25, 2007 and is headquartered in Gothenburg, Sweden.

Gustave Roussy Foundation is a leading European cancer center that specializes in the treatment of rare cancers and complex tumors. Gustave Roussy Foundation is located in Villejuif and Chevilly-Larue, France, and has 3,200 health professionals and 4,100 professionals working on its two campuses. The institute provides expert care for all cancers at every stage of life and caters to almost 50,000 patients per year. It is a source of diagnostic and therapeutic advances and integrates research, patient care, and teaching. The institute offers personalized management that combines innovation and a human-focused approach, taking into account care and physical, psychological, and social quality of life.

Deallus Consulting Ltd. operates as a life science consulting company. The company offers consulting advice in the areas of product strategy, corporate strategy, research and development, business development, manufacturing and supply strategy, and competitive analysis. The company was founded by Richard Withers, Sarah Withers and Lars Uno Jonas Pedersén in 2004 and is headquartered in London, the United Kingdom.

PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France.

GOKAP Invest (GOKAP) is a venture capital operating division of GOKAP Invest AB founded in 2017 by Clementina Osterberg. The firm is headquartered in Gothenburg, Sweden.

GOKAP Invest AB provides investment services. The private company is based in Gothenburg, Sweden and has subsidiaries in Sweden. The Swedish company was founded in 2017. The CEO is Roy Peter Jonebrant.

Alain Oncologie Consulting provides business and management consulting services. The private company is based in Paris, France. The CEO of the French company is Alain Herrera.

Ad Bio Consulting provides business and management consulting services. The private company is based in Paris, France. The CEO of the French company is Alain Herrera.

Nordlo AB offers digital solutions. It provides information technology infrastructure, cloud services, and digitalization for small and medium-sized organizations. The company was founded in 2018 and is headquartered in Stockholm, Sweden.

Part of ArchiMed SAS, Galahad Topco Ltd. is a British company founded in 2015. The company is based in London, UK. The company's description is written in non-English characters, but it appears to be related to investment and finance.

Part of ArchiMed SAS, Deallus Holdings Ltd. is a holding British company that operates subsidiaries providing competitive intelligence consulting services. The company is based in London, UK. The company was founded in 2012. The CEO is Pete Hempshall.

Galahad Midco Ltd. provides professional, scientific, and technical services. The private company is based in London, UK, and has subsidiaries in the United Kingdom. Galahad Midco was founded in 2015.

Part of Galahad Midco Ltd., Galahad Bidco Ltd. is a British company that provides strategic intelligence consultancy services. The company is based in London, UK and was founded in 2015.

Part of PharmaEngine, Inc., Pharmaengine Europe SARL develops pharmaceutical products for cancer diseases. The company is based in Paris, France. The CEO of the French company is Alain Herrera.

Gustave Roussy Transfert is a subsidiary of Gustave Roussy, the first cancer control center in France, which places innovation at the heart of care and research against cancer. The private company is based in Villejuif, France. The French company's main mission is to identify, protect, promote, and support the scientific, technological, and medical resources of Gustave Roussy. Gustave Roussy Transfert has designed a program called "Better Living Cancer" to support cancer patients during and after treatments through complementary approaches and practices to improve their quality of life. The program includes physical activity sessions, mindfulness meditation courses, and aesthetic care.

EMERCell SAS is an oncology company based in Montpellier, France. The French company is focused on developing a platform technology to produce off-the-shelf allogenic natural killer (NK) cells. The company's lead drug candidate, NK-001, is intended for the treatment of lymphoma patients who are refractory to conventional therapies. EMERCell collaborates with numerous industrial and academic partners and has received support from the Occitanie region (ADI) and Bpifrance. The company was founded in 2013 by Patrick Henno and Martin Villalba and is a member of Eurobiomed.

Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston.